Sirtex Medical Europe GmbH is a global, innovative company dedicated to the development of minimally invasive cancer therapies and advanced embolization solutions. Through continuous research and cutting-edge technologies, Sirtex contributes to improving cancer treatment, providing effective options for patients with difficult-to-treat tumors.

In Romania, the development and access to these technologies have been supported for over 10 years by the strategic partnership with Torus Pharma Company. Through its expertise and active involvement, Torus Pharma has played a key role in introducing innovative solutions such as EmboCept® S DSM and SIR-Spheres® Y-90 to the local market, significantly contributing to the modernization of treatments for patients with inoperable tumors.

Through this strong collaboration, Torus Pharma continues to bring value to the Romanian healthcare system, facilitating access to advanced therapies and supporting the advancement of interventional oncology.